Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Sata

Showing results (181-190 of 416) with videos related to

Pageof 42
Sort By:
Biochemical and Biophysical Research Communications|January 1, 2008
Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cellsHiroto Kumemura, Masaru Harada, Chikatoshi Yanagimoto, et al.
Alcoholism, Clinical and Experimental Research|December 31, 2005
Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in JapanYasuyo Morita, Takato Ueno, Nozomi Sasaki, et al.
Digestive Diseases and Sciences|April 15, 2006
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFPShiro Murashima, Masatoshi Tanaka, Makoto Haramaki, et al.
Cancer Research|May 3, 2006
Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoidsKaruppaiyah Selvendiran, Hironori Koga, Takato Ueno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2006
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-IIYoichi Yano, Fumihiko Yamashita, Kotaro Kuwaki, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2007
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33Satoko Matsueda, Akira Yamada, Yukari Takao, et al.
Journal of Medical Virology|November 17, 2012
Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: a multicenter studyHidenori Toyoda, Takashi Kumada, Noritomo Shimada, et al.
Journal of Gastroenterology and Hepatology|October 20, 2007
Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intoleranceMinoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndromeMasafumi Kumamoto, Atsushi Toyonaga, Hiroto Inoue, et al.
Journal of Gastroenterology|December 22, 2011
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1Teruko Hino-Arinaga, Tatsuya Ide, Ryoko Kuromatsu, et al.
Pageof 42

Showing results (181-190 of 416) with videos related to

Sort By:
Pageof 42
Biochemical and Biophysical Research Communications|January 1, 2008
Mutation in keratin 18 induces mitochondrial fragmentation in liver-derived epithelial cellsHiroto Kumemura, Masaru Harada, Chikatoshi Yanagimoto, et al.
Alcoholism, Clinical and Experimental Research|December 31, 2005
Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in JapanYasuyo Morita, Takato Ueno, Nozomi Sasaki, et al.
Digestive Diseases and Sciences|April 15, 2006
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFPShiro Murashima, Masatoshi Tanaka, Makoto Haramaki, et al.
Cancer Research|May 3, 2006
Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoidsKaruppaiyah Selvendiran, Hironori Koga, Takato Ueno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2006
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-IIYoichi Yano, Fumihiko Yamashita, Kotaro Kuwaki, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2007
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33Satoko Matsueda, Akira Yamada, Yukari Takao, et al.
Journal of Medical Virology|November 17, 2012
Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: a multicenter studyHidenori Toyoda, Takashi Kumada, Noritomo Shimada, et al.
Journal of Gastroenterology and Hepatology|October 20, 2007
Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intoleranceMinoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndromeMasafumi Kumamoto, Atsushi Toyonaga, Hiroto Inoue, et al.
Journal of Gastroenterology|December 22, 2011
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1Teruko Hino-Arinaga, Tatsuya Ide, Ryoko Kuromatsu, et al.
Pageof 42